Acne inversa (hidradenitis suppurativa): From diagnosis to therapy;Acne inversa (Hidradenitis suppurativa): Erkennen - Verstehen - Therapieren

Hautarzt

Volumn 64, Issue 1, 2013, Pages 55-62

  Muhlstadt M ^a   Bechara, F G ^b   Kunte, C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Biologics; Chronic inflammatory disease; Dermatologic surgery; Pain; Recurrence

Indexed keywords

ACNE INVERSA; ARTICLE; DERMATOLOGIST; INCIDENCE; PAIN; SOCIAL ISOLATION; SUPPURATIVE HIDRADENITIS;

ANTI-INFLAMMATORY AGENTS; BIOLOGICAL AGENTS; HIDRADENITIS SUPPURATIVA; HUMANS;

EID: 84872961269     PISSN: 00178470     EISSN: 14321173     Source Type: Journal    
DOI: 10.1007/s00105-012-2479-8     Document Type: Article

References (26)

1. Plewig G, Steger M (1989) Acne inversa. In: Marks R, Plewig G (Hrsg) Acne and related disorders. Dunitz, London, S 345-347
2. Kamp S, Fiehn AM, Stenderup K et al (2011) Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br J Dermatol 164:1017-1022
3. Revuz JE, Canoui-Poitrine F, Wolkenstein P et al (2008) Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 59:596-601
4. Vazquez BG, Alikhan A, Weaver AL et al (2012) Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol doi:10.1038/jid.2012.255 [Epub ahead of print]
5. Sabat R, Chanwangpong A, Schneider-Burrus S et al (2012) Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One 7:e31810
6. Nazary M, Zee HH van der, Prens EP et al (2011) Pathogenesis and pharmacotherapy of hidradenitis suppurativa. Eur J Pharmacol 672:1-8
7. Jemec GB, Wendelboe P (1998) Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 39:971-974 (Pubitemid 28547731)
8. Sartorius K, Killasli H, Oprica C et al (2012) Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained during carbon dioxide laser treatment. Br J Dermatol 166:879-883
9. Revuz J (2010) Hidradenitis suppurativa. Presse Med 39:1254-1264
10. Pink AE, Simpson MA, Brice GW et al (2011) PSENEN and NCSTN mutations in familial hidradenitis suppurativa (Acne Inversa). J Invest Dermatol 131:1568-1570
11. Li T, Wen H, Brayton C et al (2007) Epidermal growth factor receptor and notch pathways participate in the tumor suppressor function of gamma-secretase. J Biol Chem 282:32264-32273 (Pubitemid 350106457)
12. Hurley HJ (1989) Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Roenigh RK, Roenigh HH (Hrsg) Dermatologic surgery. Marcel Dekker, New York, S 729-739
13. Sartorius K, Lapins J, Emtestam L, Jemec GB (2003) Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 149:211-213 (Pubitemid 36966545)
14. Maclean GM, Coleman DJ (2007) Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa. Ann R Coll Surg Engl 89:709-712 (Pubitemid 47577786)
15. Mortimer PS, Dawber RP, Gales MA, Moore RA (1986) A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 115:263-268 (Pubitemid 16055913)
16. Mendonça CO, Griffiths CE (2006) Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol 154:977-978
17. Gener G, Canoui-Poitrine F, Revuz JE et al (2009) Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology 219:148-154
18. Boer J, Nazary M (2011) Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer? Br J Dermatol 164:170-175
19. Blok JL, Hattem S van, Jonkman MF, Horváth B (2012) Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review. Br J Dermatol doi:10.1111/bjd.12104 [Epub ahead of print]
20. Rambhatla PV, Lim HW, Hamzavi I (2012) A systematic review of treatments for hidradenitis suppurativa. Arch Dermatol 148:439-446
21. van der Zee HH, de Ruiter L, van den Broecke DG et al (2011) Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol 164:1292-1298
22. Patel RV, Clark LN, Lebwohl M, Weinberg JM (2009) Treatments for psoriasis and the risk of malignancy. J Am Acad Dermatol 60:1001-1017
23. Tierney E, Mahmoud BH, Hexsel C et al (2009) Randomized control trial fort he treatment of hidradenitis suppurativa with a neodynium-doped yttrium aluminium garnet laser. Dermatol Surg 35:1188-1198
24. Mühlstädt M, Kulichová D, Kunte C (2009) Perioperative Antibiotikaprophylaxe in der Dermatochirurgie. Update 2009. Hautarzt 60:546-549
25. Bechara FG, Hartschuh W (2010) Acne inversa. Hautarzt 61:39-46
26. Ritz JP, Runkel N, Haier J, Buhr HJ (1998) Extent of surgery and recurrence rate of hidradenitis suppurativa. Int J Colorectal Dis 13:164-168 (Pubitemid 28444875)